DEVONIAN HEALTH GROUP RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHSun, 07 Jun 2026 14:50:48 +0200https://images.finanzen.net/images/finanzen_net_neu.gifDEVONIAN HEALTH GROUP RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netDevonian Health Group Announces Grant of Stock OptionsFri, 19 Dec 2025 15:15:00 +0100https://www.finanzen.net/nachricht/aktien/devonian-health-group-announces-grant-of-stock-options-15371278

QUEBEC, Dec. 19, 2025 /CNW/ - Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD) ...

]]>https://www.finanzen.net/nachricht/aktien/devonian-health-group-announces-grant-of-stock-options-15371278Devonian Health Group Announces Grant of Stock OptionsFri, 19 Dec 2025 15:15:00 +0100https://www.finanzen.net/nachricht/aktien/devonian-health-group-announces-grant-of-stock-options-15371279

QUEBEC, Dec. 19, 2025 /PRNewswire/ - Devonian Health Group Inc. ("Devonian" or the "Company") ...

]]>https://www.finanzen.net/nachricht/aktien/devonian-health-group-announces-grant-of-stock-options-15371279Devonian Health Group Reports Financial Results of its First Quarter Ended on October 31, 2025 and Provides Corporate UpdateFri, 12 Dec 2025 14:45:00 +0100https://www.finanzen.net/nachricht/aktien/devonian-health-group-reports-financial-results-of-its-first-quarter-ended-on-october-31-2025-and-provides-corporate-update-15355316
  • Company continues preclinical studies for Thykamine™ in MASH and Fibrosis, furthering the understanding of Thykamine™'s mechanism of action.
  • Thykamine™: A New Player in the Field of Anti-Inflammatory ...

    ]]>https://www.finanzen.net/nachricht/aktien/devonian-health-group-reports-financial-results-of-its-first-quarter-ended-on-october-31-2025-and-provides-corporate-update-15355316Devonian Health Group Reports Financial Results of its First Quarter Ended on October 31, 2025 and Provides Corporate UpdateFri, 12 Dec 2025 14:45:00 +0100https://www.finanzen.net/nachricht/aktien/devonian-health-group-reports-financial-results-of-its-first-quarter-ended-on-october-31-2025-and-provides-corporate-update-15355317
    • Company continues preclinical studies for Thykamine™ in MASH and Fibrosis, furthering the understanding of Thykamine™'s mechanism of action.
    • Thykamine™: A New Player in the Field of Anti-Inflammatory ...

      ]]>https://www.finanzen.net/nachricht/aktien/devonian-health-group-reports-financial-results-of-its-first-quarter-ended-on-october-31-2025-and-provides-corporate-update-15355317